IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v41y2018i3d10.1007_s40264-017-0608-0.html
   My bibliography  Save this article

Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Author

Listed:
  • Cristina Olteanu

    (University of Alberta)

  • Neil H. Shear

    (University of Toronto
    Sunnybrook Health Sciences Centre)

  • Hall F. Chew

    (Sunnybrook Health Sciences Centre)

  • Rena Hashimoto

    (University of Toronto)

  • Raed Alhusayen

    (University of Toronto)

  • Sonia Whyte-Croasdaile

    (CAST International)

  • Yaron Finkelstein

    (The Hospital for Sick Children)

  • Marjorie Burnett

    (Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre)

  • Michael Ziv

    (Technion-Institute of Technology)

  • Shachar Sade

    (Sunnybrook Health Sciences Centre)

  • Marc G. Jeschke

    (Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre)

  • Roni P. Dodiuk-Gad

    (University of Toronto
    Technion-Institute of Technology)

Abstract

Introduction Few studies have reported the physical complications among Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) survivors. Objective The aim of this study was to comprehensively characterize the physical complications among SJS/TEN survivors and to learn about patients’ perspectives of surviving SJS/TEN. Methods SJS/TEN survivors older than 18 years of age were assessed by different methods: a medical interview; a questionnaire assessing patients’ perspectives; thorough skin, oral mucous membrane, and ophthalmic examinations; and a retrospective assessment of medical records. Results Our cohort consisted of 17 patients with a mean time of 51.6 ± 74.7 months (median 9, range 1–228) following SJS/TEN. The most common physical complications identified in the medical examination were post-inflammatory skin changes (77%), cutaneous scars (46%), dry eyes (44%), symblepharon, and chronic ocular surface inflammation (33% each). Novel physical sequelae included chronic fatigue (76%) and pruritus (53%). We also found a novel association between the number of mucous membranes affected in the acute phase of SJS/TEN and hair loss during the 6 months following hospital discharge; hair loss was reported in 88% of the group of patients who had three or more mucous membranes affected versus 29% of patients who had less than three mucous membranes involved (p = 0.0406). Following hospital discharge due to SJS/TEN, 59% of patients were followed by a dermatologist, although 88% had dermatological complications; 6% were followed by an ophthalmologist, even though 67% had ophthalmological complications; and 6% of female survivors were followed by a gynecologist, even though 27% had gynecological complications. Conclusion Survivors of SJS/TEN suffer from severe physical complications impacting their health and lives that are mostly under recognized and not sufficiently treated by medical professionals.

Suggested Citation

  • Cristina Olteanu & Neil H. Shear & Hall F. Chew & Rena Hashimoto & Raed Alhusayen & Sonia Whyte-Croasdaile & Yaron Finkelstein & Marjorie Burnett & Michael Ziv & Shachar Sade & Marc G. Jeschke & Roni , 2018. "Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis," Drug Safety, Springer, vol. 41(3), pages 277-284, March.
  • Handle: RePEc:spr:drugsa:v:41:y:2018:i:3:d:10.1007_s40264-017-0608-0
    DOI: 10.1007/s40264-017-0608-0
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-017-0608-0
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-017-0608-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:41:y:2018:i:3:d:10.1007_s40264-017-0608-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.